Chang C - Search Results

1

Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.

Ohtsu H, Xiao Z, Ishida J, Nagai M, Wang HK, Itokawa H, Su CY, Shih C, Chiang T, Chang E, Lee Y, Tsai MY, Chang C, Lee KH. Ohtsu H, et al. Among authors: chang e, chang c. J Med Chem. 2002 Nov 7;45(23):5037-42. doi: 10.1021/jm020200g. J Med Chem. 2002. PMID: 12408714

2

Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator.

Wang X, Yang Y, Guo X, Sampson ER, Hsu CL, Tsai MY, Yeh S, Wu G, Guo Y, Chang C. Wang X, et al. Among authors: chang c. J Biol Chem. 2002 May 3;277(18):15426-31. doi: 10.1074/jbc.M111218200. Epub 2002 Feb 20. J Biol Chem. 2002. PMID: 11856738 Free article.

3

Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.

Hsing AW, Chokkalingam AP, Gao YT, Wu G, Wang X, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Chiang T, Chen YL, Stanczyk FZ, Chang C. Hsing AW, et al. Among authors: chang c. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):337-41. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11927493

4

Recent advances in the TR2 and TR4 orphan receptors of the nuclear receptor superfamily.

Lee YF, Lee HJ, Chang C. Lee YF, et al. Among authors: chang c. J Steroid Biochem Mol Biol. 2002 Aug;81(4-5):291-308. doi: 10.1016/s0960-0760(02)00118-8. J Steroid Biochem Mol Biol. 2002. PMID: 12361719 Review.

5

Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.

Lee YF, Lin WJ, Huang J, Messing EM, Chan FL, Wilding G, Chang C. Lee YF, et al. Among authors: chang c. Cancer Res. 2002 Nov 1;62(21):6039-44. Cancer Res. 2002. PMID: 12414626

6

Differential and bi-directional regulation between TR2/TR4 orphan nuclear receptors and a specific ligand mediated-peroxisome proliferator-activated receptor alpha in human HaCaT keratinocytes.

Inui S, Lee YF, Chang E, Shyr CR, Chang C. Inui S, et al. Among authors: chang e, chang c. J Dermatol Sci. 2003 Feb;31(1):65-71. doi: 10.1016/s0923-1811(02)00152-4. J Dermatol Sci. 2003. PMID: 12615366

7

Reducing the agonist activity of antiandrogens by a dominant-negative androgen receptor coregulator ARA70 in prostate cancer cells.

Rahman MM, Miyamoto H, Takatera H, Yeh S, Altuwaijri S, Chang C. Rahman MM, et al. Among authors: chang c. J Biol Chem. 2003 May 30;278(22):19619-26. doi: 10.1074/jbc.M210941200. Epub 2003 Mar 20. J Biol Chem. 2003. PMID: 12649293 Free article.

8

Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells.

Yang L, Wang L, Lin HK, Kan PY, Xie S, Tsai MY, Wang PH, Chen YT, Chang C. Yang L, et al. Among authors: chang c. Biochem Biophys Res Commun. 2003 Jun 6;305(3):462-9. doi: 10.1016/s0006-291x(03)00792-7. Biochem Biophys Res Commun. 2003. PMID: 12763015

9

Mechanisms and clinical relevance of androgens and androgen receptor actions.

Kang HY, Tsai MY, Chang C, Huang KE. Kang HY, et al. Among authors: chang c. Chang Gung Med J. 2003 Jun;26(6):388-402. Chang Gung Med J. 2003. PMID: 12956285 Free article. Review.

10

Antitumor agents 222. Synthesis and anti-androgen activity of new diarylheptanoids.

Ohtsu H, Itokawa H, Xiao Z, Su CY, Shih CC, Chiang T, Chang E, Lee Y, Chiu SY, Chang C, Lee KH. Ohtsu H, et al. Among authors: chang e, chang c. Bioorg Med Chem. 2003 Nov 17;11(23):5083-90. doi: 10.1016/j.bmc.2003.08.029. Bioorg Med Chem. 2003. PMID: 14604672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,405 results

Search Page

Filters